From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Reader Remarks

Reader Remarks on:

Glyburide Outperformed Metformin in Treating Women with Gestational Diabetes

Glycemic Control

Laverne Miller, CMH Hicksville, 15 Jan 2010 6:06 PM EST

Competing interests: None declared

UKPDS, VA Study, now this small one. Glycemic control does NOT seem to matter. Metformin had better (or at least equal) outcomes of the neonates. (Isn't that the whole purpose of glycemic control???) So how could you conclude that glyburide is better?

back to top

Just like Vytorin

Neal F Devitt, La Familia Medical Center, 25 Jan 2010 2:11 PM EST

Competing interests: None declared

While the authors qualify their conclusions, this paper is hyped as showing that glyburide outperforms metformin in the treatment of gestational diabetes. Aside from the overemphasis on markers instead of clinical outcomes, the study also joins the legions of papers published in the ob/gyn journals with a pitifully small number of patients. A number this small should exclude papers from publication.

Meformin outperformed glyburide in clinical outcomes.The lower weight of newborns in the metformin group should overshadow all else in the attention given this study. Excess newborn weight has been associated with increased risk of diabetes, obesity and cardiovascular disease later in life. Any study of treatments for gestational diabetes should model itself on studies of the outcome of premature births and present data on the health of the offspring at 5, 10 and 20 years of age.

back to top

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?



Copyright © 2012. Massachusetts Medical Society. All rights reserved.